The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Patients with Subclinical Cushing’s Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk
Abstract
Subclinical Cushing's syndrome (SCS) is increasingly being reported in incidentally discovered adrenal adenomas; its hallmark is mild autonomous cortisol hyperproduction without specific clinical signs of cortisol excess. Increased prevalence of hypertension, obesity, and impaired glucose tolerance have been described in SCS, but there is no specific study of the risk factors for cardiovascular diseases. In this cross-sectional study we assessed the cardiovascular profile in 28 consecutive SCS patients (19 women and 9 men; aged 56 +/- 10.6 yr) compared with 100 controls matched for age, gender, and body mass index. Systolic (P < 0.001) and diastolic (P < 0.005) blood pressures were higher in patients, as were fasting glucose, insulin, total cholesterol, triglycerides (all P < 0.001), and fibrinogen (P < 0.05). Moreover, the insulin resistance index was increased in patients as was the waist to hip ratio and mean carotid artery intima-media thickness (all P < 0.001). Of the patients, 60.7% had arterial hypertension, 71.4% had lipid abnormalities, 28.6% had impaired glucose tolerance, 35.7% type 2 diabetes mellitus, and 53.6% had abnormalities in hemostatic parameters. Atherosclerotic plaques were more frequent in patients (P < 0.0001). Only 4 (14.3%) patients did not have multiple risk factors for cardiovascular events. Six (21.3%) had clinical evidence of cardiovascular disease; another 11 (39.3%) had cardiovascular abnormalities as revealed by ultrasound scanning of carotid arteries and/or electrocardiogram records. These results strongly suggest that an increased cardiovascular risk profile, similar to that described in overt Cushing's syndrome, is present in SCS subjects. This finding supports the concept that chronic mild endogenous cortisol excess may have important systemic effects on the human body.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the absence of florid signs and symptoms, ACS in patients AI has been associated with hypertension (215), insulin resistance (216), type 2 diabetes mellitus (217), obesity (218), metabolic syndrome (219), and increased mortality (75).”
From Adrenal incidentaloma (2020) · cites this paper as [219]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [201]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,324
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Primary Prevention of Ischemic Stroke
Goldstein, L. B., Adams, R. J., Becker, K. J., Furberg, C. D., Gorelick, P. B., Hádemenos, G. J., Hill, M., Howard, G., Howard, V. J., Jacobs, B. S., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 902
Recommendations for Human Blood Pressure Determination by Sphygmomanometers
Kirkendall, W. M., Burton, A. C., Epstein, F. H., & Freis, E. D. (1967) · Circulation · doi:10.1161/01.cir.36.6.980 · Cited by 882
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. A. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 760
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Emoto, M., Nishizawa, Y., Maekawa, K., Hiura, Y., Kanda, H., Kawagishi, T., Shoji, T., Okuno, Y., & Morii, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.818 · Cited by 457
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 450
Cited by
Sorted by citations
Items 201–300 of 400
Loh, H. H., & Sukor, N. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0294-8 · Cited by 19
Tzanela, M., Mantzou, A., Saltiki, K., Tampourlou, M., Kalogeris, N., Hadjidakis, D., Tsagarakis, S., & Alevizaki, M. K. (2012) · PubMed · doi:10.3275/7840 · Cited by 18
Terzolo, M., Reimondo, G., & Angeli, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0473 · Cited by 18
Adrenal steroids and the metabolic syndrome
Thomson, S. P., Stump, C. S., Kurukulasuriya, L. R., & Sowers, J. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0093-4 · Cited by 17
The appearance of the adrenal glands on computed tomography in multiple endocrine neoplasia type 1
Whitley, S., Moyes, V., Park, K. M., Brooke, A., Grossman, A. B., Chew, S. L., Rockall, A., Monson, J., & Reznek, R. H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0516 · Cited by 18
Issa, B. G., Hanna, F., Fryer, A. A., Ensah, G., Ebere, I., Marshall, D., & Keevil, B. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad242 · Cited by 17
Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels
Yener, S., Comlekci, A., Akıncı, B., Seçil, M., Demir, T., Ertilav, S., & Yeşil, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345724 · Cited by 17
The mechanism of action and side effects of epidural steroids
Baqai, A., & Bal, R. (2009) · Techniques in Regional Anesthesia and Pain Management · doi:10.1053/j.trap.2009.06.009 · Cited by 17
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma
Papanastasiou, L., Παππά, Θ., Samara, C., Apostolopoulou, G., Tsiavos, V., Markou, Α., Alexandraki, K., Piaditis, G. P., Chrousos, G. P., & Kaltsas, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02707.x · Cited by 17
Oki, K., Yamane, K., Nakanishi, S., Nakashima, R., Jitsuiki, K., & Kohno, N. (2009) · Endocrine · doi:10.1007/s12020-009-9246-3 · Cited by 16
Wang, D., Ji, Z., Li, H., & Zhang, Y. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170531 · Cited by 16
Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI)
Babińska, A., Kaszubowski, M. F., & Sworczak, K. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0066 · Cited by 16
Huang, C. L., Chang, L., Sheu, J.-Y., Huang, Y., Chen, J., Lai, C., & Wu, V. (2025) · Hypertension Research · doi:10.1038/s41440-025-02172-5 · Cited by 16
Delibaşı, T., Karbek, B., Bozkurt, N. Ç., Çakır, E., Güngüneş, A., Ünsal, Ö. Ö., Aslan, M. S., & Çakal, E. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000053 · Cited by 15
Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing’s syndrome
Tateishi, Y., Kouyama, R., Mihara, M., Doi, M., Yoshimoto, T., & Hirata, Y. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0204 · Cited by 15
Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas
Yener, S., Çömlekçi, A., Yüksel, F., Sevınç, A. I., Ertilav, S., & Yeşil, S. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.009 · Cited by 15
Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess
Kelsall, A., Iqbal, A., & Newell-Price, J. D. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.19 · Cited by 15
Multiple corticosteroid abnormalities in cats with hyperaldosteronism
Langlois, D. K., Mazaki‐Tovi, M., Harro, C. C., & Refsal, K. R. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16224 · Cited by 15
Minami, I., Tateno, T., Yoshimoto, T., Doi, M., Izumiyama, H., Akashi, T., & Hirata, Y. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1809 · Cited by 15
The Recovery of Hypothalamic-Pituitary-Adrenal Axis Is Rapid in Subclinical Cushing Syndrome
Kim, H. K., Yoon, J. H., Jeong, Y. A., & Kang, H. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.4.592 · Cited by 15
Subclinical Cushing’s Syndrome
Beuschlein, F., & Reincke, M. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_7 · Cited by 15
Moon, S. J., Jang, H. N., Kim, J. H., & Moon, M. K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1012 · Cited by 14
Ren, X., Nan, M., & Zhang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399311 · Cited by 14
Hormonal and metabolic evaluation of adrenal incidentalomas
Wagnerová, H., Dudasova, D., & Lazúrová, I. (2009) · Neoplasma · doi:10.4149/neo_2009_06_521 · Cited by 14
Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism
León‐Justel, A., Mangas, M. Á., Fontan, R., Castro-Luque, J., Moreno, E. V., Madrazo‐Atutxa, A., del Rey, T. H., Martin‐Rodríguez, J. F., Soto‐Moreno, A., & Leal‐Cerro, A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.08.013 · Cited by 14
Clinical, Research and Treatment Approaches to Affective Disorders
Juruena, M. F. (2012) · InTech eBooks · doi:10.5772/1482 · Cited by 14
Autonomous hypercortisolism: definition and clinical implications
Reimondo, G., Puglisi, S., Pia, A. R., & Terzolo, M. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02884-5 · Cited by 14
When to Intervene for Subclinical Cushing's Syndrome
Hsieh, L. B., MacKinney, E. C., & Wang, T. S. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.011 · Cited by 14
Naka, M., Kadoya, M., Kosaka‐Hamamoto, K., Morimoto, A., Miyoshi, A., Kakutani, M., Shoji, T., & Koyama, H. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0478 · Cited by 14
Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
Szychlińska, M., Baranowska-Jurkun, A., Matuszewski, W., Wołos-Kłosowicz, K., & Bandurska-Stankiewicz, E. M. (2020) · Medicina · doi:10.3390/medicina56020069 · Cited by 14
Huayllas, M. K. P., Smith, L. M., Gallagher, J. C., Netzel, B. C., Singh, R. J., & Kater, C. E. (2021) · Clinical Endocrinology · doi:10.1111/cen.14445 · Cited by 14
Maehana, T., Tanaka, T., Itoh, N., Masumori, N., & Tsukamoto, T. (2012) · Indian Journal of Urology · doi:10.4103/0970-1591.98461 · Cited by 13
Donadio, F., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Carletto, M., Castellani, M., Dellavedova, L., Scillitani, A., Beck-Peccoz, P., & Chiodini, I. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346511 · Cited by 13
Huayllas, M. K. P., Sirineni, G. K. R., Smith, L. M., Gallagher, J. C., Singh, R., Netzel, B. C., & Kater, C. E. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.21753 · Cited by 13
Brett, B. E., Koko, K. B., Doumbia, H. O. Y., Koffi, F. K., Assa, S. E., Zahé, K. Y. A. S., Faye-Ketté, H., Kati-Coulibaly, S., Kort, R., Sybesma, W., et al. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105255 · Cited by 13
Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis
Felšöci, M., Schroner, Z., Petrovičová, J., & Lazúrová, I. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1497-8 · Cited by 13
Síndrome de Cushing: situaciones especiales
Iriarte, M. J. G. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)71408-1 · Cited by 13
Ohno, Y., Sone, M., Inagaki, N., Takeda, Y., Kurihara, I., Tsuiki, M., Ichijo, T., Wada, N., Katabami, T., Ogawa, Y., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02790 · Cited by 14
Dullaart, R. P. F., Schols, J. L., van der Steege, G., Zelissen, P. M. J., Sluiter, W. J., & van Beek, A. P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03196.x · Cited by 13
Hypertension and Cushing’s syndrome: hunt for the red flag
Martino, D., Canu, L., Bonaventura, I., Vitiello, C., Sparano, C., & Cozzolino, A. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02453-9 · Cited by 12
Rebellato, A., Grillo, A., Dassie, F., Sonino, N., Maffei, P., Martini, C., Paoletta, A., Fabris, B., Carretta, R., & Fallo, F. (2014) · Endocrine · doi:10.1007/s12020-014-0164-7 · Cited by 12
Ishida, A., Igarashi, K., Ruike, Y., Ishiwata, K., Naito, K., Kono, S., Deguchi, H., Fujimoto, M., Shiga, A., Suzuki, S., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14385 · Cited by 12
Ünal, A. D., Aytürk, S., Aldemir, D., & Tütüncü, N. B. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8519362 · Cited by 11
Mauclère-Denost, S., Duron-Martinaud, S., Nunes, M. L., Gatta‐Cherifi, B., Fagour, C., Rault, A., Gosse, P., & Tabarin, A. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.03.005 · Cited by 11
Virilizing Ovarian Leydig Cell Tumor in A Woman with Subclinical Cushing Syndrome
Diab, D., Faiman, C., SIPERSTEIN, A. E., Grossman, W., Rabinowitz, L., & Hamrahian, A. H. (2008) · Endocrine Practice · doi:10.4158/ep.14.3.358 · Cited by 11
Ruiz, A., Michalopoulou, T., Megía, A., Näf, S., Simón‐Muela, I., Solano, E., Martínez, L., & Vendrell, J. J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13048 · Cited by 12
Tamada, D., Kitamura, T., Otsuki, M., Oshino, S., Saitoh, Y., & Shimomura, I. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0446 · Cited by 10
Lazúrová, I., Spišáková, D., Wagnerová, H., Habalová, V., Dravecká, I., Petrášová, D., Drahovská, I., & Pundová, L. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-0064-2 · Cited by 10
Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH
Olsen, H., Olofsson, L., & Mjöman, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12295 · Cited by 10
Draft of the clinical practice guidelines “Adrenal incidentaloma”
Beltsevich, D. G., Troshina, E. A., Mel'nichenko, G. A., Platonova, N. M., Ladygina, D. O., & Chevais, A. (2021) · Endocrine Surgery · doi:10.14341/serg12712 · Cited by 10
TSH ratio as a novel diagnostic method for Cushing’s syndrome
Tamada, D., Kitamura, T., Takahara, M., Tanaka, T., Takeda, M., Otsuki, M., & Shimomura, I. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0101 · Cited by 10
The role of confirmatory tests in the diagnosis of primary aldosteronism
Huang, C., Tu, K., Fan, K., Tsai, C., Wang, W., Wang, S., Wu, C.-Y., Hu, Y.-H., Huang, S.-H., Liu, H.-W., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.04.022 · Cited by 9
Ragnarsson, Ó., Trimpou, P., Oleröd, G., & Landin‐Wilhelmsen, K. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.007 · Cited by 9
Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences.
Bohdanowicz-Pawlak, A., Szymczak, J., Waszczuk, E., Bolanowski, M., & Bednarek-Tupikowska, G. (2013) · PubMed · Cited by 9
Risk Estimator for Adrenal Tumor Functionality
Sadler, C., & Goldfarb, M. R. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2524-0 · Cited by 9
Villéon, B. D. L., Bonnet, S., Gouya, H., Groussin, L., Tenenbaum, F., Gaujoux, S., & Dousset, B. E. (2016) · Surgery · doi:10.1016/j.surg.2016.03.008 · Cited by 9
Ognjanovic, S. I., Μacut, D., Petakov, M. S., Kovačević, V. E., Isailovic, T. V., Antić, I. B., Ilic, D. S., Popovic, B. M., Bogavac, T., Pekmezovic, T. D., et al. (2016) · Journal of Medical Biochemistry · doi:10.1515/jomb-2016-0020 · Cited by 9
Update on the risks of benign adrenocortical incidentalomas
Dalmazi, G. D. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000341 · Cited by 9
Comparison of echocardiographic findings in patients with nonfunctioning adrenal incidentalomas
İmga, N. N., Elalmış, Ö. U., Tuna, M. M., Dogan, B. A., Şahin, D., Gursoy, T., Yalçın, Y., Berker, D. S., & Güler, S. (2017) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2017.04.002 · Cited by 9
Overt Diabetes Mellitus in a Patient with Combined Primary Aldosteronism and Cushing's Syndrome
Sasaki, N., Iwase, M., Arima, H., Nohara, S., Bandai, S., Yao, T., Fujii, K., & Iida, M. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1855 · Cited by 9
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas
Sandooja, R., Saini, J., Kittithaworn, A., Garcia, R. G., Dogra, P., Atkinson, E. J., Yu, K., Fell, V. M., Simha, V., Connelly, M. A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae392 · Cited by 8
Incidentalomas suprarrenales: experiencia clínica en los hospitales de Castilla-La Mancha
Lamas, C., Palma, M., Martín, D., de Frutos, V. Á., López, M., & Marco, A. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)72708-1 · Cited by 8
Reimondo, G., Allasino, B., Coletta, M., Pia, A. R., Peraga, G., Zaggia, B., Massaglia, C., Paccotti, P., & Terzolo, M. (2015) · International Journal of Endocrinology · doi:10.1155/2015/674734 · Cited by 8
Ayari, H., Legedz, L., Lantelme, P., Feugier, P., Randon, J., Cerutti, C., Lohez, O. D., Scoazec, J., Li, J. Y., GHARBI-CHIHI, J., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01064.x · Cited by 8
Adrenal incidentalomas and subclinical Cushing’s syndrome
Abdelmannan, D. K., & Aron, D. C. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9141-5 · Cited by 8
Paşa, S., Altıntaş, A., Tümer, C., Demirçin, M., Çil, T., Bayan, K., Danış, R., Tüzün, Y., Atayan, Y., Ayyildiz, O. M., et al. (2010) · Cited by 8
Khawandanah, D., El-Asmar, N., & Arafah, B. M. (2018) · Endocrine · doi:10.1007/s12020-018-1769-z · Cited by 8
Update on the Diagnosis of Cushing Syndrome
Liu, H., & Crapo, L. M. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000162374.56442.ea · Cited by 8
Adaptive and maladaptive cortisol responses to pediatric obesity
Soros, A., Zadik, Z., & Chalew, S. A. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.04.020 · Cited by 8
Pattern of adrenal morphology and function in patients with acromegaly
Παππά, Θ., Papanastasiou, L., Koutmos, S., Tsiavos, V., Roussaki, P., Zilos, A., Ragkou, D., Kaltsas, G., & Piaditis, G. P. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02580.x · Cited by 7
Unusual case of pheochromocytoma presenting with diabetic ketoacidosis
Sedhai, Y. R., Reddy, K., Patel, D., & Lozada, J. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-216961 · Cited by 7
Koracevic, G. P., Stojkovic, M., Lović, D. B., Pavlović, M., Kostić, T. L., Kutlesic, M. S., Mićić, S., Koraćević, M., & Djordjević, M. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666181005122339 · Cited by 7
Vasilev, V., Matrozova, J., Elenkova, A. P., & Zacharieva, S. (2013) · Open Medicine · doi:10.2478/s11536-013-0199-9 · Cited by 7
Tabarin, A., Bardet, S., Bertherat, J. Y., Chabre, O., Dupas, B., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Rohmer, V., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.002 · Cited by 7
Starker, L. F., Prieto, P. A., Liles, J. S., Cao, H. S. T., Grubbs, E. G., Lee, J. E., Perrier, N. D., & Graham, P. H. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.04.001 · Cited by 7
Ersöz, F., Erbil, Y., Sarı, S., Salmaslıoğlu, A., İşsever, H., Aral, F., & Özarmağan, S. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1012-z · Cited by 7
Enberg, U., Hennings, J., Volpe, C., Hellman, P., Höög, A., Hamberger, B., & Thoren, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345750 · Cited by 7
Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
Resmini, E. (2014) · Advances in Endocrinology · doi:10.1155/2014/231432 · Cited by 7
Management of the Clinically Inapparent Adrenal Mass
Copeland, P. M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00018 · Cited by 7
An Overlooked Disease: Minimal Autonomous Cortisol Secretion (MACS). A Narrative Review
Farah, S., Nasr, L., & Fares, J. E. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303266569231129101847 · Cited by 6
Dhingra, A., Ganie, M. A., Dharmshaktu, P., Chakraborty, S., Jyotsna, V. P., & Gupta, N. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0879-5122 · Cited by 6
The Role of the Clinical Laboratory in the Diagnosis of Cushing Syndrome
Garcia, C. A., Biller, B. M. K., & Klibanski, A. (2003) · Pathology Patterns Reviews · doi:10.1309/5bhrvaq1vjbg43w4 · Cited by 6
Lin, D., Lin, J., Hu, X., Liu, Y., Zhang, J., Zhang, L., Jiang, J., Li, X., & Guo, J. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1108 · Cited by 5
Etiologies of Cushing’s Syndrome
Newell-Price, J. D. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_2 · Cited by 6
A Case of Acute Aortic Dissection Type B Associated to Cushing's Syndrome
Petramala, L. (2009) · Journal of Clinical Medicine Research · doi:10.4021/jocmr2009.02.1224 · Cited by 6
Therapeutic Repurposing of Antidiabetic Drugs in Diabetes-associated Comorbidities
Pathak, K., Pathak, M. P., Saikia, R., Gogoi, U., Das, R. J., Patowary, P., Kaishap, P. P., Bordoloi, S., Das, J., Sarma, H., et al. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230516150404 · Cited by 6
Oßwald, A., Quinkler, M. O., Dalmazi, G. D., Deutschbein, T., Rubinstein, G., Ritzel, K., Zopp, S., Bertherat, J. Y., Beuschlein, F., & Reincke, M. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.8.4 · Cited by 5
Kuzu, İ., Zuhur, S. S., Demir, N., Aktas, G., Öztürk, F. Y., & Altuntaş, Y. (2016) · Endokrynologia Polska · doi:10.5603/ep.a2016.0028 · Cited by 5
Screening Tests for Hypercortisolism in Patients With Adrenal Incidentaloma
Ferreira, L., Oliveira, J. C., & Palma, I. (2018) · Journal of Endocrinology and Metabolism · doi:10.14740/jem510w · Cited by 5
Adrenal Causes of Cushing’s Syndrome
Cavagnini, F., & Giraldi, F. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00103-7 · Cited by 5
Metabolic and cardiovascular impact of non-functioning adrenal adenomas: A clinical dilemma
Yener, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.005 · Cited by 5
Kunz, S. L., Meng, Y., Schneider, H., Brunnenkant, L., Höhne, M., Kuehnle, T., Reincke, M., Theodoropoulou, M., & Bidlingmaier, M. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106610 · Cited by 4
Muscogiuri, G., Albertelli, M., Arnaldi, G., Barrea, L., Bellastella, G., Bonomi, M., Caputo, M., Caprio, M., Cignarelli, A., Gioia, L. D., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02862-y · Cited by 4
Morphological and Phytochemical Study of Cirsium Arvense from District Mardan Pakistan
Ullah, S., Shakir, L., & Ullah, R. (2023) · doi:10.61440/jbbr.2023.v1.01 · Cited by 4
Zhao, X., Zhou, J., Lyu, X., Li, Y., Ma, L., Liu, Y., Fan, H., & Zhang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-74452-y · Cited by 4
Arac, Y., Yaylalı, G. F., Topsakal, Ş., & Onder, C. (2024) · Cureus · doi:10.7759/cureus.72221 · Cited by 4
Local Angiotensin Pathways in Human Carotid Atheroma: Towards a Systems Biology Approach
Bricca, G., Legedz, L., Nehme, A., Ayari, H., Paultre, C. Z., Hodroj, W., Li, J., Randon, J., Lohez, O. D., Dhaouadi, N., et al. (2015) · Conference Papers in Science · doi:10.1155/2015/593086 · Cited by 4
Doença de cushing subclínica: relato de três casos e revisão da literatura
Silva, B. C. C., Baruqui, A. M., Barbosa, V. E., Pena, G. P., Campos, M. H. D. F., Ramos, A. V., & Dias, E. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400018 · Cited by 4
Turcu, A. F., & Auchus, R. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_10 · Cited by 4
Atar, R. V. (2020) · Northern Clinics of Istanbul · doi:10.14744/nci.2019.54771 · Cited by 4
Metadata
- Authors
- Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Tauchmanovà, Libuse
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-11
- Volume
- 87
- Issue
- 11
- Pages
- 4872-4878
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2151843074
- Cited by
- 400
- References
- 47
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 14 · 2022: 8 · 2021: 20 · 2020: 14 · 2019: 20 · 2018: 19 · 2017: 12 · 2016: 22 · 2015: 21 · 2014: 19 · 2013: 24 · 2012: 27
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- subclinical Cushing's syndrome, adrenal adenoma, cardiovascular risk, hypertension, insulin resistance, impaired glucose tolerance, type 2 diabetes, dyslipidemia, atherosclerosis, carotid intima-media thickness, hemostatic disorders, cortisol excess
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adult, Aged, Arteriosclerosis, Blood Glucose, Blood Pressure, Body Constitution, Cardiovascular Diseases, Carotid Arteries, Cholesterol, Cushing Syndrome, Diabetes Mellitus, Type 2, Diastole, Fasting, Female, Fibrinogen, Humans, Hyperlipidemias, Hypertension, Insulin, Insulin Resistance, Male, Middle Aged, Risk Factors, Systole, Triglycerides, Ultrasonography, Body Mass Index, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review